Disease | gastroparesis |
Phenotype | C0011860|type 2 diabetes |
Sentences | 2 |
PubMedID- 22961573 | The current study is the first clinical investigation to demonstrate that, compared with placebo, a single subcutaneous injection of rm-131 compared with placebo significantly accelerated ge t1/2 of solids (the most accepted measurement of gastroparesis) (7,30) in patients with type 2 diabetes who had previously documented dge and current symptoms suggestive of gastroparesis. |
PubMedID- 21813291 | Obesity and symptoms suggestive of gastroparesis in patients with type 2 diabetes and neuropathy. |
Page: 1